News from the FDA/CDC
News from the FDA/CDC
Children and COVID: New-case counts offer dueling narratives
Data from the American Academy of Pediatrics appear to conflict with information provided by the Centers for Disease Control and Prevention.
News from the FDA/CDC
Children and COVID: Hospitalizations provide a tale of two sources
Thanksgiving travel seems to have had little effect on new pediatric cases.
News
FDA OKs first fecal transplant therapy for recurrent C. difficile
The application for Rebyota received priority review and had orphan drug and breakthrough therapy designation.
Feature
U.S. flu activity already at mid-season levels
Nationally, 6% of all outpatient visits were because of flu or flu-like illness for the week of Nov. 13-19.
News from the FDA/CDC
Children and COVID: Weekly cases maintain a low-level plateau
White House coordinator says that a holiday COVID-19 surge is unlikely.
News from the FDA/CDC
Children and COVID: Weekly cases continue to hold fairly steady
The latest hospital admission data may be telling a somewhat different story.
News from the FDA/CDC
Children and COVID: New cases increase for second straight week
Extended declines in ED visits and hospitalizations may be reversing.
News from the FDA/CDC
CDC warns of early uptick in respiratory disease
As influenza viruses, respiratory syncytial virus, SARS-CoV-2, and rhinovirus/enterovirus simultaneously circulate, the agency cautioned that this...
News from the FDA/CDC
FDA expands tenofovir alafenamide (Vemlidy) use to adolescents with chronic HBV
The study met its primary endpoint of percentage of patients with HBV DNA levels less than 20 IU/mL at 24 weeks of therapy.
News from the FDA/CDC
Mid-October flulike illness cases higher than past 5 years
The 2022-2023 season is already “gathering speed … about a month early,” one expert said.
News from the FDA/CDC
Children and COVID: Weekly cases can’t sustain downward trend
Hospitalizations and emergency department visits may be on the rise again.